IRAK1 and neoplasm: We found that IRAK1 is expressed in much higher levels in poorly differentiated high grade (grade 3) tumours compared with relatively well-differentiated grade 1–2 tumours, as revealed by both Oncomine analysis and IHC verification (Fig. 4a).